🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A prospective, open-label, phase 2 study to explore CAIX expression through...
Status
Terminated
Location
University of California, Los Angeles(UCLA)
Start Date
2023-06-06
Trial ID
NCT05563272
Treatments Being Tested
The purpose of this study is to identify changes in Carbonic Anhydrase IX (...
Status
Recruiting
Location
NYU Langone Health
Start Date
2025-09-15
Trial ID
NCT07179770
Treatments Being Tested
89Zr-TLX250 is a carbonic anydrase IX (CAIX)-targeted imaging agent that is...
Status
Completed
Location
Yokohama City University Hospital
Start Date
2020-08-01
Trial ID
NCT04496089
Treatments Being Tested
Precision medicine represents a major goal in oncology. It has its underpin...
Status
Recruiting
Location
CHU de Nantes
Start Date
2025-11-04
Trial ID
NCT06735560
Treatments Being Tested
89Zr-TLX250 is under clinical development as a diagnostic agent targeting c...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2024-11-06
Trial ID
NCT06750419
Treatments Being Tested
The purpose of this study is to evaluate the use of 89Zr-labeled girentuxim...
Status
Completed
Location
ICO René Gauducheau
Start Date
2021-09-21
Trial ID
NCT04758780
Treatments Being Tested
This is an open label, single-arm, multicentre dose escalation (Part 1) and...
Status
Recruiting
Location
Macquarie University
Start Date
2023-05-23
Trial ID
NCT05868174
Treatments Being Tested
The purpose of this study is to evaluate the use of 89Zr-labeled girentuxim...
Status
Completed
Location
Institut de cancerologie de l'Ouest
Start Date
2021-12-15
Trial ID
NCT04897763
Treatments Being Tested
89Zr-TLX250 is under clinical development as a diagnostic agent targeting c...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2019-08-15
Trial ID
NCT03849118
Treatments Being Tested
The study is designed to evaluate the safety, tolerability, radiation dosim...
Status
Completed
Location
Peking University Cancer Hospital & Institute
Start Date
2023-06-26
Trial ID
NCT05861778
Treatments Being Tested